CD274 and neoplasm: The mechanism of ICIs is restoring anti-tumor immunity by blocking immune checkpoints, such as cytotoxic T-lymphocyte antigen 4 (CTLA-4), programmed cell death protein 1 (PD-1), and programmed cell death protein ligand 1 (PD-L1) [6].